Endex 8.75 % w/v Oral Suspension for Sheep

País: Irlanda

Língua: inglês

Origem: HPRA (Health Products Regulatory Authority)

Ingredientes ativos:

Triclabendazole, Levamisole hydrochloride

Disponível em:

Elanco Europe Ltd

Código ATC:

QP52AC30

DCI (Denominação Comum Internacional):

Triclabendazole, Levamisole hydrochloride

Dosagem:

8.75 percent weight/volume

Forma farmacêutica:

Oral suspension

Tipo de prescrição:

LM: Licensed Merchant as defined in relevant national legislation

Grupo terapêutico:

Sheep

Área terapêutica:

combinations of benzimidazoles and related substances

Indicações terapêuticas:

Endoparasiticide

Status de autorização:

Authorised

Data de autorização:

2016-10-21

Características técnicas

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Endex 8.75 % w/v Oral Suspension for Sheep
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Oral suspension.
A white to off-white aqueous suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Sheep.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the simultaneous treatment and control of mature and immature
infections, including inhibited stages of stomach
worms (_Haemonchus, Ostertagia, Trichostrongylus axei_), gut worms
(_Trichostrongylus, Cooperia, Nematodirus,_
_Busonstomum, Gaigeria, Chabertia, Oesophagostomum_) and lung worms
(_Dictyocaulus)_ as well as all forms of liver fluke
infection (early immature, immature and adult stages of_ Fasciola
hepatica and Fasciola gigantica_ susceptible to
triclabendazole).
For the treatment and control of nematodes resistant to benzimidazoles
and probenzimidazoles, macrolide anthelmintics
(e.g. ivermectin), salicylanides and tetrahydropyrimidines.
4.3 CONTRAINDICATIONS
Do not administer to animals with known hypersensitivity to the active
ingredients.
Do not administer to goats.
Active Substances
Triclabendazole
5.0
% w/v
Levamisole hydrochloride
3.75
% w/v
Excipients
Methyl parahydroxybenzoate (E218)
0.095 % w/v
Propyl parahydroxybenzoate (E216)
0.035 % w/v
Benzoic acid (E210)
0.1
% w/v
Sodium metabisulphite (E223)
0.25
% w/v
For a full list of excipients, see section 6.1
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_1_
_/_
_1_
_0